Medpace Holdings Inc vs United Airlines Holdings Inc — how do they compare? Medpace Holdings Inc trades at $602.96 (market cap $16.90B), while United Airlines Holdings Inc trades at $125.11 (market cap $41.00B). The key difference: United Airlines Holdings Inc is far larger — about 2.4× Medpace Holdings Inc's market cap, and Medpace Holdings Inc is trading nearer its 52-week high, United Airlines Holdings Inc nearer its low. Which is the better fit depends on your goals.
| MEDP | UAL | |
|---|---|---|
Market Cap | $16.90B | $41.00B |
Sector | Technology | Industrials |
52-Week High | $620.59 | $136.11 |
52-Week Low | $393.42 | $85.21 |
Enterprise Value | $16.52B | $58.03B |
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $600.32, down 0.35% on the day, with a bullish technical signal supported by moving averages. The stock shows strong fundamentals with Q2 2026 earnings beating estimates at $4.25 per share versus $3.98 expected, and revenue growth projected from $2.53B in 2025 to $2.8B in 2026. Recent news highlights record bookings and raised guidance, though valuation ratios remain elevated with a P/E of 35.58 and P/B of 38.95.
Outlook remains positive driven by earnings momentum and strong backlog visibility, but risks include premium valuation compression and ongoing legal scrutiny. Analyst consensus is cautious with 73.7% hold ratings, though institutional interest persists with California State Teachers Retirement System increasing its position by 22.1% in Q1 2026.
United Airlines (UAL) trades at $125.32, up 1.26% today, with strong technical momentum and consistent earnings beats. The stock shows bullish moving averages and trades near resistance at $126. Fundamentals are solid, with revenue growth to $59.07B in 2025 and net income of $3.35B, supported by a low P/E of 11.83. Recent news highlights fuel cost management and merger speculation, though operational disruptions pose near-term risks.
Outlook remains positive with a consensus price target of $167.73, implying 34% upside. Opportunities include robust travel demand and cost controls, but risks involve volatile fuel prices, competitive pressure, and execution challenges. Analyst sentiment is strongly bullish with 66% buy ratings, though investors should monitor margin sustainability amid economic uncertainties.
Trailing returns across standard periods
Latest headlines on both assets
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →United Airlines is a major U.S. network carrier. United's hubs include San Francisco, Chicago, Houston, Denver, Los Angeles, New York/Newark, and Washington, D.C. United operates a hub-and-spoke system that is more focused on international travel than legacy peers.
Read more on UAL →